Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma
Abstract Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death worldwide, because recurrence often occurs in most HCC patients undergoing hepatectomy. It is necessary to identify patients with high risk for recurrence and adopt effective therapies. An obstacle to monitor patien...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/00143853c4ef4ec2ba9214ccd9394d38 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|